论文部分内容阅读
卫生部麻醉品协调会议办公室与美国司法部禁毒署(DEA)联系安排,由中国医药工业公司和青海制药厂一行五人组成考察组于1988年10月赴美进行麻醉药品生产管理考察。访问了八个单位:两个政府部门(DEA和FDA);三个生产麻醉药品原料药的工厂;两个医院(纽约的Sloan kettering癌症治疗中心和乔其华盛顿大学附属医院);一家麻醉药品批发商(AMFAC)。 美国吸毒严重。DEA负责禁毒,并负责麻醉药品监督控制,严格管理,防止医疗和科研需用的麻醉药品转为毒品。控制办法是:
The Office of Narcotics Coordination Meeting of the Ministry of Health and the U.S. Department of Justice contacted the Agency for Drug Control (DEA). A team consisting of China National Pharmaceutical Industry Corporation and Qinghai Pharmaceutical Factory made up a delegation of five to visit the United States in October 1988 to conduct a study on the production control of narcotic drugs. Visited eight units: two government agencies (DEA and FDA); three manufacturing plants for narcotic drugs; two hospitals (Sloan kettering Cancer Center in New York and the George Washington University Affiliated Hospital); a wholesale narcotics Business (AMFAC). Drug abuse in the United States is serious. DEA is responsible for drug control and is responsible for the supervision and control of narcotic drugs, and strictly controls the conversion of narcotic drugs used for medical and scientific research to drugs. The control method is: